Chemotherapy sensitivity tests
In recent years more and more tests have appeared on the market, which are supposed to project how successful a certain chemotherapy will be for a certain patient. However all of these tests have the same problems:

  • The question is no longer asked whether chemotherapy even makes sense, rather the question now becomes, which chemotherapy? Naturally this pleases all pharmaceutical manufacturers and a person must fundamentally question the “supposed” successes of this test.
  • Various processes such as gene control, ATP measurements etc. are used. However the actual question is naturally: How meaningful is the result, in reality?
  • Can laboratory conditions even be applied to people?

Also the various statements from within the allopathic community are also confusing. Hundreds of scientists write (and oncologists again and again cite what they write in their statements) that a chemotherapy is of no value at low p53 values, at the same time most therapies are administered without measuring a p53 gene value. For many years a p53 test or sensitivity test have been available. However most doctors do not use them. Why not? Is it because they themselves do not believe in their significance?. Are the costs too high, or is it because the health insurance companies do not want to pay for these tests because they are not “scientifically recognized?”

If you should want chemotherapy, particularly for epithelial tumors, then insist on a sensitivity test. What have you got to lose?

Read more about Chemotherapy sensitivity tests by reading a book.
Translate »